{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T21:58:17Z","timestamp":1788991097923,"version":"build-2803163510"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Preeclampsia (PE) is a multisystem pregnancy complication. Factors pointing to a placental origin are the development of the pathology only during pregnancy, and its disappearance in the post-partum period.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Here, we aim to identify early predictive biomarkers. Whole blood and serum samples were collected at the time of the first event of PE (V1) and same samples after remote delivery (30-60 postpartum days, V2). These two samples enabled investigation of PE markers found in V1 but absent in V2. To confirm that these candidates are associated with PE, an investigation of associated placental biopsy was also realized (J0).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Our study identified a specific signature of PE including five Gene Ontology clusters including \u201cangiogenesis and differentiation\u201d, \u201ccell-cycle\u201d, \u201ccell-adhesion\u201d, \u201cinflammatory response\u201d and \u201ccellular metabolism\u201d. DUSP1 (Dual Specificity Phosphatase 1) gene was found specifically modulated in PE. PE women have a higher concentration of DUSP1 in serum compared to healthy donors. Interesting, at a distance from childbirth (V2), DUSP1 finds a rate like control group showing its predictive interest as a promising predictive biomarker of PE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>The investigation of DUSP1 in a prospective study with a larger cohort, including the severity aspect of the disease, is necessary to confirm its value as a predictive biomarker in PE.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1576240","type":"journal-article","created":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:12:33Z","timestamp":1757563953000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Dual specificity phosphatase 1 as a non-invasive circulating biomarker candidate in preeclampsia"],"prefix":"10.3389","volume":"16","author":[{"given":"Jonatane","family":"Andrieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Donet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Cocallemen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Charbonnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"No\u00e9mie","family":"Resseguier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Paganini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"M\u00e8ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Mezouar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Bretelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-023-00417-6","article-title":"Pre-eclampsia","volume":"9","author":"Dimitriadis","year":"2023","journal-title":"Nat Rev Dis Primer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32335-7","article-title":"Pre-eclampsia","volume":"398","author":"Chappell","year":"2021","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.014","article-title":"Preeclampsia\u2014Pathophysiology and clinical presentations: JACC state-of-the-art review","volume":"76","author":"Ives","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2201295","article-title":"& Chronic hypertension and pregnancy (CHAP) trial consortium. Treatment for mild chronic hypertension during pregnancy","volume":"386","author":"Tita","year":"2022","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31963-4","article-title":"Planned early delivery or expectant management for late preterm pre-eclampsia (PHOENIX): a randomised controlled trial","volume":"394","author":"Chappell","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2020.09.047","article-title":"Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways","volume":"226","author":"Redman","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41420-022-01171-6","article-title":"PD-L1 enhances migration and invasion of trophoblasts by upregulating ARHGDIB via transcription factor PU.1","volume":"8","author":"Zhang","year":"2022","journal-title":"Cell Death Discov"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M900553200","article-title":"Genetic variation in ANGPTL4 provides insights into protein processing and function *","volume":"284","author":"Yin","year":"2009","journal-title":"J Biol Chem"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2002630117","article-title":"Pivotal role of the transcriptional co-activator YAP in trophoblast stemness of the developing human placenta","volume":"117","author":"Meinhardt","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"103780","DOI":"10.1016\/j.ebiom.2021.103780","article-title":"Clinical tools and biomarkers to predict preeclampsia","volume":"75","author":"MacDonald","year":"2021","journal-title":"EBioMedicine"},{"key":"B12","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren","year":"2022","journal-title":"Pregnancy Hypertens"},{"key":"B13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.230620","article-title":"Screening for preeclampsia risk and prophylaxis with acetylsalicylic acid","volume":"195","author":"Jain","year":"2023","journal-title":"CMAJ Can Med Assoc J J Assoc Medicale Can"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/uog.18816","article-title":"ASPRE trial: performance of screening for preterm pre-eclampsia","volume":"50","author":"Rolnik","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty895","article-title":"Heavy-tailed prior distributions for sequence count data: removing the noise and preserving large differences","volume":"35","author":"Zhu","year":"2019","journal-title":"Bioinformatics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02434","article-title":"Full-term human placental macrophages eliminate Coxiella burnetii through an IFN-\u03b3 autocrine loop","volume":"10","author":"Mezouar","year":"2019","journal-title":"Front Microbiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18015","article-title":"Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered","volume":"111","author":"Luttun","year":"2003","journal-title":"J Clin Invest"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13184","article-title":"Metabolomics identifies placental dysfunction and confirms flt-1 (FMS-like tyrosine kinase receptor 1) biomarker specificity","volume":"74","author":"Austdal","year":"2019","journal-title":"Hypertension"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1172\/JCI17189","article-title":"Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia","volume":"111","author":"Maynard","year":"2003","journal-title":"J Clin Invest"},{"key":"B23","doi-asserted-by":"publisher","first-page":"103.e1","DOI":"10.1016\/j.ajog.2015.08.034","article-title":"Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11\u201313 weeks gestation","volume":"214","author":"O\u2019Gorman","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.003215","article-title":"Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study","volume":"128","author":"Chappell","year":"2013","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.04.020","article-title":"Differential placental gene expression in preeclampsia","volume":"199","author":"Enquobahrie","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000286761.11436.67","article-title":"Placenta-derived, cellular messenger RNA expression in the maternal blood of preeclamptic women","volume":"110","author":"Okazaki","year":"2007","journal-title":"Obstet Gynecol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082638","article-title":"Evaluation of current and new biomarkers in severe preeclampsia: A microarray approach reveals the VSIG4 gene as a potential blood biomarker","volume":"8","author":"Textoris","year":"2013","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.3390\/genes13112134","article-title":"Identification of key genes and pathways associated with preeclampsia by a WGCNA and an evolutionary approach","volume":"13","author":"Kondoh","year":"2022","journal-title":"Genes"},{"key":"B29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3390\/biology9040062","article-title":"& Ahmad asnawi, A. W. A review of candidate genes and pathways in preeclampsia-an integrated bioinformatical analysis","volume":"9","author":"Mohamad","year":"2020","journal-title":"Biology"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13763","article-title":"Combining biomarkers to predict pregnancy complications and redefine preeclampsia: the angiogenic-placental syndrome","volume":"1979","author":"Stepan","year":"2020","journal-title":"Hypertens Dallas Tex"},{"key":"B31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/2045-3701-2-24","article-title":"DUSPs, to MAP kinases and beyond","volume":"2","author":"Huang","year":"2012","journal-title":"Cell Biosci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14815","article-title":"DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer","volume":"8","author":"Shen","year":"2017","journal-title":"Oncotarget"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2005.06.022","article-title":"Dual-specificity phosphatase DUSP1 protects overactivation of hypoxia-inducible factor 1 through inactivating ERK MAPK","volume":"309","author":"Liu","year":"2005","journal-title":"Exp Cell Res"},{"key":"B34","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1095\/biolreprod.112.102723","article-title":"The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis","volume":"87","author":"Tal","year":"2012","journal-title":"Biol Reprod"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0178549","article-title":"Identification of key microRNAs and genes in preeclampsia by bioinformatics analysis","volume":"12","author":"Luo","year":"2017","journal-title":"PloS One"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1530\/REP-21-0036","article-title":"TORC2\/3-mediated DUSP1 upregulation is essential for human decidualization","volume":"161","author":"Xu","year":"2021","journal-title":"Reproduction"},{"key":"B37","doi-asserted-by":"publisher","first-page":"113095","DOI":"10.1016\/j.intimp.2024.113095","article-title":"Identification of driving genes of recurrent miscarriage based on transcriptome sequencing and immunoinfiltration analysis","volume":"143","author":"Yang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2016.1203483","article-title":"Role for DUSP1 (dual-specificity protein phosphatase 1) in the regulation of autophagy","volume":"12","author":"Wang","year":"2016","journal-title":"Autophagy"},{"key":"B39","doi-asserted-by":"publisher","first-page":"108953","DOI":"10.1016\/j.biopha.2019.108953","article-title":"miR-141-5p regulate ATF2 via effecting MAPK1\/ERK2 signaling to promote preeclampsia","volume":"115","author":"Wang","year":"2019","journal-title":"Biomed Pharmacother"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1576240\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T04:12:34Z","timestamp":1757563954000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1576240\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,11]]},"references-count":39,"alternative-id":["10.3389\/fendo.2025.1576240"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1576240","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,11]]},"article-number":"1576240"}}